Navigation Links
DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
Date:8/4/2009

rmal volunteers.

For further information regarding DOR BioPharma, Inc., please visit the Company's website at www.dorbiopharma.com.

This press release contains forward-looking statements that reflect DOR BioPharma, Inc.'s current expectations about its future results, performance, prospects and opportunities. Statements that are not historical facts, such as "anticipates," "believes," "intends," or similar expressions, are forward-looking statements. These statements are subject to a number of risks, uncertainties and other factors that could cause actual events or results in future periods to differ materially from what is expressed in, or implied by, these statements. DOR cannot assure you that it will be able to successfully develop or commercialize products based on its technology, including orBec(R) and LPM(TM), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will not exceed projected levels, that product development and commercialization efforts will not be reduced or discontinued due to difficulties or delays in clinical trials or due to lack of progress or positive results from research and development efforts, that it will be able to successfully obtain any further grants and awards, maintain its existing grants which are subject to performance, enter into any biodefense procurement contracts with the US Government or other countries, that the US Congress may not pass any legislation that would provide additional funding for the Project BioShield program, that it will be able to patent, register or protect its technology from challenge and products from competition or maintain or expand its license agreements with its current licensors, or that its business st
'/>"/>

SOURCE DOR BioPharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
2. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
3. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
4. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
5. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
6. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
7. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
8. Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG
9. Keryx Biopharmaceuticals to Present at Bank of America Investment Conference
10. Morria Biopharmaceuticals Plc Announces Appointment of Dr. Rosemary Mazanet as Interim Chief Executive Officer
11. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... DIEGO, Dec. 15 Aethlon Medical, Inc. ... Dr. Jeff Schorey and Dr. Wayne Comper ... Exosome Sciences, Inc. (ESI). Both Dr. Schorey and ... field. ESI, a wholly owned subsidiary of Aethlon ... that the Hemopurifier®, a medical device being advanced ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
(Date:12/15/2009)... On January 20th, 2010, the inaugural ... Publication Professionals (ISMPP) will be held at the ... than 100 attendees are expected at this prestigious ... editors, publishers, medical writers and medical agencies to ... the impact of guidelines and regulations such as ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
Breaking Biology Technology:Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 2Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 3Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 4Aethlon Medical Appoints Jeff Schorey and Wayne Comper to Exosome Sciences Advisory Board 5Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2
... are many consultants and consulting firms that use slogans and ... the inquisitive ear of executive management. Economic development equals broadband ... a slogan or phrase rings true, it stands the test ... hats it is printed on. , ,I believe EDEBC is ...
... - Businesses in metropolitan Milwaukee and perhaps throughout Wisconsin ... advance digital inclusiveness as Milwaukee moves toward completion of ... Milwaukee , having finalized a contract with Midwest ... Internet network, will pursue five goals that are key ...
... background in city and state government is joining a ... federal grant money for start-up bioscience and technology companies ... Consulting Group has added Henry Sanders, Jr. to ... relations venture, hamilton.gsp, which was created in collaboration with ...
Other Biology Technology:Locations must have connectivity to be viable 2Locations must have connectivity to be viable 3Locations must have connectivity to be viable 4Businesses could bridge digital divide in Milwaukee with used computers 2Businesses could bridge digital divide in Milwaukee with used computers 3
(Date:12/15/2009)... the near future, consumers can look forward to ... as laptops, PDAs and mobile phones. This is ... harvesting technologies which are critical elements for power ... and systems. , Analog IC design is the ... harvesting. To pre-position the nation in advanced analog ...
(Date:12/15/2009)... Dec. 15 The PTR Group, a leading ... that it has agreed to sponsor three high school ... Robotics Competition ( http://usfirst.org ). ,, The ... teams in three different states. The teams from ... TX, and James Madison HS in Vienna, VA all ...
(Date:12/14/2009)... novel antifreeze molecule in a freeze-tolerant Alaska beetle able ... all previously described biological antifreezes that contain protein, this ... It is composed of a sugar and a fatty ... cells of organisms. , "The most exciting part ... whole new kind of antifreeze that may work in ...
Breaking Biology News(10 mins):NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3The PTR Group Announces Financial and Technical Support to US FIRST Robotics Competition Teams 2Scientists isolate new antifreeze molecule in Alaska beetle 2Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 1Snoring Isn 26apos 3Bt Sexy LLC Launches Survey to Determine Extent of Drowsy Drivers on Land Sea and In The Air 49556 2From Jack the Ripper to great white sharks 8940 1Fate in fly sensory organ precursor cells could explain human immune disorder 8938 1Fate in fly sensory organ precursor cells could explain human immune disorder 8938 2Fate in fly sensory organ precursor cells could explain human immune disorder 8938 3
... Medical Institute investigator from Albany, New York, and an ... combined their expertise to identify two peculiar features of ... disease. Their findings could help scientists develop a safe ... kill up to 30 percent of those infected. , ...
... transfusion medicine is an ongoing challenge to blood ... Creutzfeldt-Jakob Disease (vCJD), emerge. An update on the ... human form of Bovine Spongiform Encephalopathy (BSE), commonly ... transmission through blood transfusion was presented here at ...
... the Vaccine and Gene Therapy Institute (VGTI) at Oregon ... to better detect future monkeypox or smallpox outbreaks. The ... outbreak in the Midwest -- monkeypox is closely related ... outbreak was larger than the 72 cases reported by ...
Other Biology News:North & South American researchers find architectural abnormalities in T. cruzi ribosome 2North & South American researchers find architectural abnormalities in T. cruzi ribosome 3North & South American researchers find architectural abnormalities in T. cruzi ribosome 4New results validating Pall prion reduction filter disclosed at ISBT Congress 2New results validating Pall prion reduction filter disclosed at ISBT Congress 3Researchers develop new testing methods for potential monkeypox or smallpox outbreak 2Researchers develop new testing methods for potential monkeypox or smallpox outbreak 3
... unique combination of Coulter volume and ... and accurate cell counting. This flow ... UV, allowing flexible fluorochrome selection for ... only achievable with larger, more expensive ...
... 250 g monoclonal antibody irreversibly crosslinked ... ~13 g of PDH complex from heart ... bovine heart mitochondria for control immunocapture. ,The ... isolation of PDH from small amounts of ...
... PULSin may be superior to transfection in ... transfection, with PULSin you can study lethal ... course of proteins in cells. Likewise, delivery ... than traditional RNA interference experiments. ,With ...
Reacti-Bind DNA Coating Solution...
Biology Products: